Page last updated: 2024-12-08

oxytocin, pen(1)-(4-mephe)(2)-thr(4)-orn(8)-

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

oxytocin, Pen(1)-(4-MePhe)(2)-Thr(4)-Orn(8)-: RN given refers to all (L)-isomer; an oxytocin antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID159308
SCHEMBL ID15511119
MeSH IDM0177875

Synonyms (9)

Synonym
opmpto
106128-84-1
1-pen-2-(mephe)-4-thr-8-orn-oxytocin
oxytocin, penicillaminyl(1)-(4-methylphenylalanyl)(2)-threonyl(4)-ornithine(8)-
(1-penicillamine,2-p-methyl-phenylalanine,4-threonine,8-ornithine)vasotocin
oxytocin, pen(1)-(4-mephe)(2)-thr(4)-orn(8)-
p(phe(me)(2),thr(4))ovt
oxytocin, 1-(3-mercapto-l-valine)-2-(4-methyl-l-phenylalanine)-4-l-threonine-8-l-ornithine-
SCHEMBL15511119

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Naproxen sodium at both dosage levels prolonged gestation by 24 h or longer, doubled the duration of parturition, and markedly increased fetal mortality and mortality incidence."( Myometrial oxytocin receptors and prostaglandin in the parturition process in the rat.
Chan, WY; Chen, DL, 1992
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's7 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]